As of 2025-10-22, the EV/EBITDA ratio of ACADIA Pharmaceuticals Inc (ACAD) is
-28.65.
EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Acadia's latest enterprise value
is 3,588.46 mil USD. Acadia's TTM EBITDA according to its financial statements is
-125.24 mil USD. Dividing these 2
quantities gives us the above Acadia EV/EBITDA ratio.
|
Range |
Selected |
| Trailing P/E multiples |
13.0x - 14.9x |
13.8x |
| Forward P/E multiples |
14.7x - 16.2x |
15.2x |
| Fair Price |
(9.67) - 26.51 |
7.37 |
| Upside |
-145.4% - 24.6% |
-65.3% |